Mindfulness-Based Self-Management Program Using a Mobile App for Patients With Pulmonary Hypertension: Single-Arm Feasibility Study
Yuka Takita, Junko Morishita, Sunre Park, Ayumi Goda, Takumi Inami, Hanako Kikuchi, Takashi Kohno, Masaharu Kataoka, Daisuke Fujisawa · JMIR Cardio · 2025
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
JMIR Cardio · JMIR Publications · article · 2025
Abstract
BACKGROUND: Mindfulness-based interventions have been applied across various chronic illnesses, but no tailored program exists for individuals with pulmonary hypertension (PH). OBJECTIVE: This study aimed to develop and evaluate the feasibility of a mindfulness-based self-management program for patients with PH, delivered online to accommodate their limited mobility. METHODS: A single-arm pre-post study was conducted using an eight-session, weekly videoconference program incorporating PH self-management education and elements of mindfulness-based cognitive therapy. A mobile application linked to an Apple Watch was used to support symptom monitoring and mindfulness awareness.
Outcomes included PH-related symptoms; quality of life (emPHasis-10); depression (PHQ-9); anxiety (GAD-7); resilience (CD-RISC); and loneliness (UCLA Loneliness Scale-short version). Assessments occurred at baseline, week 4, and program completion. Exit interviews explored perceived changes and experiences. RESULTS: Twelve participants (mean age 41.8, SD 10.5 years; range 26-56 years) were enrolled, and nine completed the program (75% retention). Participants valued the online format and Apple Watch integration, while noting a need for optional on-demand sessions.
Qualitative analysis identified themes such as increased self-awareness, use of meditation for pain management, and enhanced self-compassion. Quantitative analysis showed significant changes across three time points (baseline, week 4, week 8) for emPHasis-10 (χ²₂=9.742; P = .008) and CD-RISC (χ²₂=7.267; P = .03). Trends toward change were observed for PHQ-9 (χ²₂=4.750; P = .09) and GAD-7 (χ²₂=5.067; P = .08), but week-12 data were limited (n=5). No significant changes in loneliness were observed. CONCLUSIONS: The program appeared to support patients with PH in managing symptoms and emotions and suggested potential improvements in quality of life.
These preliminary findings warrant evaluation in a future randomized controlled trial. CLINICALTRIAL: UMIN Clinical Trials Registry UMIN000044075; https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050319.
Open the resolved locator · 10.2196/79639
Metadata licence: OpenAlex metadata (CC0)